Laserfiche WebLink
HF100 NINTH ENGROSSMENT REVISOR BD 1­10100-9 <br />281.1 (2) not more than 1.80 grams of codeine per 100 milliliters or not more than 90 milligrams <br />281.2 per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic <br />281.3 amounts; <br />281.4 (3) not more than 1.80 grams of dihydrocodeine per 100 milliliters or not more than 90 <br />281.5 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized <br />281.6 therapeutic amounts; <br />281.7 (4) not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than <br />281.8 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized <br />281.9 therapeutic amounts; <br />281.10 (5) not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not <br />281.11 more than 25 milligrams per dosage unit, with one or more active, nonnarcotic ingredients <br />281.12 in recognized therapeutic amounts; <br />281.13 (6) not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with <br />281.14 one or more active, nonnarcotic ingredients in recognized therapeutic amounts. <br />281.15 (f) Anabolic steroids, human growth hormone, and chorionic gonadotropin. <br />281.16 (1) Anabolic steroids, for purposes of this subdivision, means any drug or hormonal <br />281.17 substance, chemically and pharmacologically related to testosterone, other than estrogens, <br />281.18 progestins, cortico steroids, and dehydroepiandrosterone, and includes: <br />281.19 (i) 3 [beta],17 [beta]-dihydroxy-5 [alpha]-androstane; <br />281.20 (ii) 3 [alpha], 17 [beta] -dihydroxy-5 [alpha] -androstane; <br />281.21 (iii) androstanedione (5 [alpha]-androstan-3,17-dione); <br />281.22 (iv) 1-androstenediol (3 [beta],17 [beta]-dihydroxy-5 [alpha]-androst-l-ene; <br />281.23 (v) 3 [alpha],17 [beta]-dihydroxy-5 [alpha]-androst-l-ene); <br />281.24 (vi) 4-androstenediol (3 [beta], 17 [beta] -dihydroxy-androst-4-ene); <br />281.25 (vii) 5-androstenediol (3 [beta], 17 [beta] -dihydroxy-androst-5-ene); <br />281.26 (viii) 1-androstenedione (5 [alpha]-androst-l-en-3,17-dione); <br />281.27 (ix) 4-androstenedione (androst-4-en-3,17-dione); <br />281.28 (x) 5-androstenedione (androst-5-en-3,17-dione); <br />281.29 (xi) bolasterone (7 [alpha], 17 [alpha] -dimethyl- 17 [beta] -hydroxyandrost-4-en-3 -one); <br />281.30 (xii) boldenone (17[beta]-hydroxyandrost-1,4-diene-3-one); <br />Article 8 Sec. 2. 281 <br />